Lv6
1710 积分 2024-01-11 加入
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
1个月前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
1个月前
已完结
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
1个月前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
1个月前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
1个月前
已完结
Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial
1个月前
已完结
Structures of human γδ T cell receptor-CD3 complex
1个月前
已完结
皖公网安备34019202002308
